

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 6.52351431 |
| 2 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 5.80739232 |
| 3 | regulation of regulatory T cell differentiation (GO:0045589) | 5.27776511 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 5.00968031 |
| 5 | negative regulation of B cell apoptotic process (GO:0002903) | 4.99481794 |
| 6 | protein neddylation (GO:0045116) | 4.94135649 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90020201 |
| 8 | positive regulation of interleukin-17 production (GO:0032740) | 4.85818325 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.75030042 |
| 10 | regulation of immunoglobulin secretion (GO:0051023) | 4.60226852 |
| 11 | DNA double-strand break processing (GO:0000729) | 4.51039099 |
| 12 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.48672561 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.46998234 |
| 14 | proteasome assembly (GO:0043248) | 4.41172451 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38716581 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.38716581 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38716581 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38716581 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38716581 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.38716581 |
| 21 | chaperone-mediated protein transport (GO:0072321) | 4.32282616 |
| 22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.26411563 |
| 23 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.14153287 |
| 24 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.04408097 |
| 25 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.04000239 |
| 26 | negative regulation of ligase activity (GO:0051352) | 4.04000239 |
| 27 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.03983986 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.03539339 |
| 29 | establishment of viral latency (GO:0019043) | 4.02764282 |
| 30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.99119600 |
| 31 | protein deneddylation (GO:0000338) | 3.98759289 |
| 32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.91484651 |
| 33 | ATP synthesis coupled proton transport (GO:0015986) | 3.91484651 |
| 34 | DNA damage response, detection of DNA damage (GO:0042769) | 3.85035984 |
| 35 | cullin deneddylation (GO:0010388) | 3.78627374 |
| 36 | positive regulation of isotype switching (GO:0045830) | 3.78360335 |
| 37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.76123914 |
| 38 | signal peptide processing (GO:0006465) | 3.66606589 |
| 39 | positive regulation of DNA recombination (GO:0045911) | 3.63309252 |
| 40 | termination of RNA polymerase III transcription (GO:0006386) | 3.53429038 |
| 41 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.53429038 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.52979535 |
| 43 | ribosome assembly (GO:0042255) | 3.47371205 |
| 44 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46701668 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.45646210 |
| 46 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.44197194 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.41868276 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40823511 |
| 49 | respiratory chain complex IV assembly (GO:0008535) | 3.39728760 |
| 50 | regulation of B cell apoptotic process (GO:0002902) | 3.39433005 |
| 51 | response to host immune response (GO:0052572) | 3.39257446 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39257446 |
| 53 | amino acid salvage (GO:0043102) | 3.36776326 |
| 54 | L-methionine salvage (GO:0071267) | 3.36776326 |
| 55 | L-methionine biosynthetic process (GO:0071265) | 3.36776326 |
| 56 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.36218820 |
| 57 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.36218820 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.35532236 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.35532236 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.35532236 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 3.34689932 |
| 62 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.32636006 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.31895966 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31700262 |
| 65 | DNA deamination (GO:0045006) | 3.29528263 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29082005 |
| 67 | positive regulation of ligase activity (GO:0051351) | 3.27232518 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.26018371 |
| 69 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.25470331 |
| 70 | regulation of interferon-alpha production (GO:0032647) | 3.23627509 |
| 71 | protein complex biogenesis (GO:0070271) | 3.22148619 |
| 72 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.19003227 |
| 73 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.17764585 |
| 74 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.17764585 |
| 75 | respiratory electron transport chain (GO:0022904) | 3.16793068 |
| 76 | response to host (GO:0075136) | 3.15092884 |
| 77 | response to host defenses (GO:0052200) | 3.15092884 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15092884 |
| 79 | GTP biosynthetic process (GO:0006183) | 3.15079837 |
| 80 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.13756208 |
| 81 | daunorubicin metabolic process (GO:0044597) | 3.13076695 |
| 82 | polyketide metabolic process (GO:0030638) | 3.13076695 |
| 83 | doxorubicin metabolic process (GO:0044598) | 3.13076695 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11227077 |
| 85 | electron transport chain (GO:0022900) | 3.10463341 |
| 86 | neutrophil activation involved in immune response (GO:0002283) | 3.09379782 |
| 87 | response to peptidoglycan (GO:0032494) | 3.08930355 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07180420 |
| 89 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07150581 |
| 90 | protein localization to kinetochore (GO:0034501) | 3.06343899 |
| 91 | regulation of ligase activity (GO:0051340) | 3.05752613 |
| 92 | B cell homeostasis (GO:0001782) | 3.04302839 |
| 93 | negative regulation of mast cell activation (GO:0033004) | 3.01614459 |
| 94 | cytochrome complex assembly (GO:0017004) | 3.00864728 |
| 95 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.00463088 |
| 96 | CENP-A containing nucleosome assembly (GO:0034080) | 2.99867978 |
| 97 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99394923 |
| 98 | regulation of helicase activity (GO:0051095) | 2.99310639 |
| 99 | negative regulation of B cell proliferation (GO:0030889) | 2.96560221 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94622716 |
| 101 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.93222172 |
| 102 | NADH dehydrogenase complex assembly (GO:0010257) | 2.93222172 |
| 103 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.93222172 |
| 104 | chromatin remodeling at centromere (GO:0031055) | 2.92782991 |
| 105 | DNA ligation (GO:0006266) | 2.92306877 |
| 106 | rRNA modification (GO:0000154) | 2.91096700 |
| 107 | 7-methylguanosine mRNA capping (GO:0006370) | 2.90264859 |
| 108 | regulation of cilium movement (GO:0003352) | 2.89373010 |
| 109 | negative regulation of protein ubiquitination (GO:0031397) | 2.88598534 |
| 110 | dendritic cell chemotaxis (GO:0002407) | 2.88374300 |
| 111 | protein targeting to mitochondrion (GO:0006626) | 2.87686808 |
| 112 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.86596304 |
| 113 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.86596304 |
| 114 | isotype switching (GO:0045190) | 2.86596304 |
| 115 | single strand break repair (GO:0000012) | 2.86461796 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.85896190 |
| 117 | cellular extravasation (GO:0045123) | 2.85469280 |
| 118 | positive regulation of interleukin-12 production (GO:0032735) | 2.84901655 |
| 119 | protein localization to mitochondrion (GO:0070585) | 2.83684498 |
| 120 | histone mRNA metabolic process (GO:0008334) | 2.81263627 |
| 121 | RNA capping (GO:0036260) | 2.80960674 |
| 122 | 7-methylguanosine RNA capping (GO:0009452) | 2.80960674 |
| 123 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.80247597 |
| 124 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79429507 |
| 125 | leukocyte aggregation (GO:0070486) | 2.76570351 |
| 126 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.75485415 |
| 127 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.75485415 |
| 128 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.75485415 |
| 129 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.75485415 |
| 130 | negative regulation of sister chromatid segregation (GO:0033046) | 2.75485415 |
| 131 | neutrophil activation (GO:0042119) | 2.75197578 |
| 132 | metaphase plate congression (GO:0051310) | 2.73639223 |
| 133 | I-kappaB phosphorylation (GO:0007252) | 2.72844218 |
| 134 | protein K11-linked ubiquitination (GO:0070979) | 2.72767595 |
| 135 | ribosome biogenesis (GO:0042254) | 2.71679477 |
| 136 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.71420084 |
| 137 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.71420084 |
| 138 | transcription from mitochondrial promoter (GO:0006390) | 2.71067863 |
| 139 | UTP biosynthetic process (GO:0006228) | 2.69903154 |
| 140 | histamine secretion (GO:0001821) | 2.69237178 |
| 141 | positive regulation of heat generation (GO:0031652) | 2.68650357 |
| 142 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68344801 |
| 143 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68255434 |
| 144 | NIK/NF-kappaB signaling (GO:0038061) | 2.67477029 |
| 145 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.66970424 |
| 146 | chondrocyte proliferation (GO:0035988) | 2.65314089 |
| 147 | granulocyte activation (GO:0036230) | 2.64991868 |
| 148 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.64713748 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.61867058 |
| 150 | dendritic cell migration (GO:0036336) | 2.58325684 |
| 151 | myeloid dendritic cell activation (GO:0001773) | 2.58185378 |
| 152 | regulation of germinal center formation (GO:0002634) | 2.57896369 |
| 153 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56990359 |
| 154 | cellular response to zinc ion (GO:0071294) | 2.52828716 |
| 155 | detection of other organism (GO:0098543) | 2.51998399 |
| 156 | negative regulation of granulocyte differentiation (GO:0030853) | 2.51888086 |
| 157 | hepatocyte apoptotic process (GO:0097284) | 2.51778238 |
| 158 | regulation of DNA endoreduplication (GO:0032875) | 2.50068674 |
| 159 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.49321152 |
| 160 | positive regulation of macrophage differentiation (GO:0045651) | 2.48499326 |
| 161 | interferon-gamma production (GO:0032609) | 2.48425497 |
| 162 | cell adhesion mediated by integrin (GO:0033627) | 2.47170185 |
| 163 | regulation of integrin activation (GO:0033623) | 2.46168650 |
| 164 | substrate-dependent cell migration (GO:0006929) | 2.46014552 |
| 165 | superoxide anion generation (GO:0042554) | 2.45371984 |
| 166 | regulation of B cell proliferation (GO:0030888) | 2.45256718 |
| 167 | regulation of interleukin-12 production (GO:0032655) | 2.44267590 |
| 168 | detection of external biotic stimulus (GO:0098581) | 2.44263000 |
| 169 | B cell proliferation (GO:0042100) | 2.41465516 |
| 170 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.40978428 |
| 171 | axon extension involved in axon guidance (GO:0048846) | 2.40978428 |
| 172 | regulation of fever generation (GO:0031620) | 2.39935179 |
| 173 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39451767 |
| 174 | ganglion development (GO:0061548) | 2.37182609 |
| 175 | respiratory burst (GO:0045730) | 2.37145709 |
| 176 | neutrophil mediated immunity (GO:0002446) | 2.36958349 |
| 177 | immunoglobulin mediated immune response (GO:0016064) | 2.36815755 |
| 178 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.36208069 |
| 179 | myeloid dendritic cell differentiation (GO:0043011) | 2.36074269 |
| 180 | macrophage activation (GO:0042116) | 2.36062833 |
| 181 | regulation of mast cell activation (GO:0033003) | 2.35719464 |
| 182 | negative regulation of interleukin-12 production (GO:0032695) | 2.34513441 |
| 183 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.34483332 |
| 184 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.32568077 |
| 185 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.31312735 |
| 186 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.31188512 |
| 187 | detection of biotic stimulus (GO:0009595) | 2.30279893 |
| 188 | glomerular visceral epithelial cell development (GO:0072015) | 2.29832889 |
| 189 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.28661959 |
| 190 | germinal center formation (GO:0002467) | 2.27098269 |
| 191 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.25476645 |
| 192 | leukocyte cell-cell adhesion (GO:0007159) | 2.25397645 |
| 193 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.25095293 |
| 194 | positive regulation of response to biotic stimulus (GO:0002833) | 2.25077373 |
| 195 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.24591279 |
| 196 | positive regulation of interferon-beta production (GO:0032728) | 2.24194478 |
| 197 | natural killer cell mediated immunity (GO:0002228) | 2.23909067 |
| 198 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.23909067 |
| 199 | positive regulation of interferon-gamma production (GO:0032729) | 2.23393576 |
| 200 | regulation of B cell differentiation (GO:0045577) | 2.22264704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.14671534 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.85093699 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38916439 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.23075007 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.02264779 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82702644 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.70211761 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69618339 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.60490601 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.43527657 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40040634 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.27346776 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.14946465 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.96448841 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.94716759 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.93431189 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.91951217 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86163961 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.82171856 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.79982856 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71371432 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.61300548 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.59840001 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.58629149 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55430280 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.55260683 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52027535 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.48062711 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43935215 |
| 30 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.39954614 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39282729 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27474600 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23508922 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23470519 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18092524 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.14420764 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14204348 |
| 38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.08721598 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.08081285 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06704491 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03232454 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.02913104 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.98127341 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.95934608 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89920532 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85476625 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82056808 |
| 48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80064187 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79912443 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79138411 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75438820 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.70513738 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69366315 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68907471 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68157136 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.67501398 |
| 57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.67260871 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.64549790 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62879420 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61366924 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58455820 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56376969 |
| 63 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54939953 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53221524 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52869377 |
| 66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.49141013 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48354410 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48334581 |
| 69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48146004 |
| 70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48059702 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.46608036 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.45470761 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45141538 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42682901 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42534778 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41960789 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41578441 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40609888 |
| 79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38367948 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37699986 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37606171 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37327449 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36669205 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35344419 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.34571552 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33962109 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33338275 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.32689132 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32630243 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32370825 |
| 91 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32327014 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.31697416 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30726632 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29429686 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28373766 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28275180 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27570551 |
| 98 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26658152 |
| 99 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.25831552 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25021015 |
| 101 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24842686 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.24494200 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24369103 |
| 104 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24062335 |
| 105 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23435253 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22239877 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21664409 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21643733 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19331295 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19061040 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18937345 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18091207 |
| 113 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.17680601 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17169875 |
| 115 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16626327 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15262804 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15262804 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14785174 |
| 119 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14658874 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14625344 |
| 121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12929105 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12767764 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12739781 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11844025 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10753492 |
| 126 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.10519026 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09732879 |
| 128 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09579962 |
| 129 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09489656 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09277718 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08649702 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07470320 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07164058 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06510110 |
| 135 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06387483 |
| 136 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05165484 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04916909 |
| 138 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04658068 |
| 139 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04455867 |
| 140 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04194066 |
| 141 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03769720 |
| 142 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01968400 |
| 143 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01555103 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01195896 |
| 145 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00860064 |
| 146 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.99968795 |
| 147 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98975589 |
| 148 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97988437 |
| 149 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97873274 |
| 150 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97873274 |
| 151 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97778493 |
| 152 | MYB_26560356_Chip-Seq_TH1_Human | 0.97083845 |
| 153 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96776087 |
| 154 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96498197 |
| 155 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96005519 |
| 156 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95873335 |
| 157 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94299736 |
| 158 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92310207 |
| 159 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92200283 |
| 160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91334228 |
| 161 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90928351 |
| 162 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89910482 |
| 163 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89862147 |
| 164 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88892265 |
| 165 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.88498246 |
| 166 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.87691729 |
| 167 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87044875 |
| 168 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86802901 |
| 169 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86183300 |
| 170 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85939585 |
| 171 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85891486 |
| 172 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85694440 |
| 173 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85553310 |
| 174 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85363886 |
| 175 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85335992 |
| 176 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85146588 |
| 177 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84951549 |
| 178 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84276518 |
| 179 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81586407 |
| 180 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81586407 |
| 181 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81350941 |
| 182 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81068694 |
| 183 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80924529 |
| 184 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.80157185 |
| 185 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79380415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.06701995 |
| 2 | MP0001529_abnormal_vocalization | 3.98613309 |
| 3 | MP0008058_abnormal_DNA_repair | 3.53705313 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.52861268 |
| 5 | MP0008057_abnormal_DNA_replication | 3.43178097 |
| 6 | MP0008789_abnormal_olfactory_epithelium | 2.93777484 |
| 7 | MP0003786_premature_aging | 2.79720750 |
| 8 | MP0003436_decreased_susceptibility_to | 2.55174070 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.53357344 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.48188390 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.45073671 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.43829035 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.38592167 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.35819130 |
| 15 | MP0005387_immune_system_phenotype | 2.34833686 |
| 16 | MP0001790_abnormal_immune_system | 2.34833686 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.28133155 |
| 18 | MP0009785_altered_susceptibility_to | 2.27829417 |
| 19 | MP0002419_abnormal_innate_immunity | 2.24390389 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.23476620 |
| 21 | MP0006035_abnormal_mitochondrial_morpho | 2.19302659 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.18904053 |
| 23 | MP0005499_abnormal_olfactory_system | 2.18413383 |
| 24 | MP0005394_taste/olfaction_phenotype | 2.18413383 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.15499283 |
| 26 | MP0003693_abnormal_embryo_hatching | 2.15035546 |
| 27 | MP0001800_abnormal_humoral_immune | 2.14312957 |
| 28 | MP0003111_abnormal_nucleus_morphology | 2.08792872 |
| 29 | MP0002736_abnormal_nociception_after | 2.01937687 |
| 30 | MP0005503_abnormal_tendon_morphology | 2.01139196 |
| 31 | MP0005671_abnormal_response_to | 2.00364398 |
| 32 | MP0003136_yellow_coat_color | 1.98952178 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.98306664 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.94409473 |
| 35 | MP0003724_increased_susceptibility_to | 1.94381463 |
| 36 | MP0003011_delayed_dark_adaptation | 1.91771375 |
| 37 | MP0000604_amyloidosis | 1.91335777 |
| 38 | MP0003077_abnormal_cell_cycle | 1.90181695 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.87678731 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.87313823 |
| 41 | MP0006054_spinal_hemorrhage | 1.86469448 |
| 42 | MP0008877_abnormal_DNA_methylation | 1.85744167 |
| 43 | MP0002723_abnormal_immune_serum | 1.83555499 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.83406826 |
| 45 | MP0001819_abnormal_immune_cell | 1.82078878 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.80640000 |
| 47 | MP0003303_peritoneal_inflammation | 1.79892594 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.78130381 |
| 49 | MP0003718_maternal_effect | 1.76316480 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.76126016 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.75980936 |
| 52 | MP0002006_tumorigenesis | 1.75407044 |
| 53 | MP0002822_catalepsy | 1.72610368 |
| 54 | MP0005025_abnormal_response_to | 1.71840303 |
| 55 | MP0001661_extended_life_span | 1.70354373 |
| 56 | MP0000685_abnormal_immune_system | 1.69011394 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.67293734 |
| 58 | MP0004510_myositis | 1.66341459 |
| 59 | MP0006072_abnormal_retinal_apoptosis | 1.64654275 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.63063586 |
| 61 | MP0003186_abnormal_redox_activity | 1.62793164 |
| 62 | MP0001727_abnormal_embryo_implantation | 1.61165805 |
| 63 | MP0003045_fibrosis | 1.57737337 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.56687441 |
| 65 | MP0002090_abnormal_vision | 1.56615095 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.55221880 |
| 67 | MP0002405_respiratory_system_inflammati | 1.53914214 |
| 68 | MP0004947_skin_inflammation | 1.53540576 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.53061180 |
| 70 | MP0003448_altered_tumor_morphology | 1.52100709 |
| 71 | MP0006082_CNS_inflammation | 1.51998174 |
| 72 | MP0003195_calcinosis | 1.51745829 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.49481978 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.48738307 |
| 75 | MP0002398_abnormal_bone_marrow | 1.48688672 |
| 76 | MP0005310_abnormal_salivary_gland | 1.46612838 |
| 77 | MP0001485_abnormal_pinna_reflex | 1.46095139 |
| 78 | MP0000858_altered_metastatic_potential | 1.44279101 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.44212424 |
| 80 | MP0004147_increased_porphyrin_level | 1.43771744 |
| 81 | MP0003091_abnormal_cell_migration | 1.42313381 |
| 82 | MP0002933_joint_inflammation | 1.40972625 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.38017126 |
| 84 | MP0001984_abnormal_olfaction | 1.37405620 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.37294193 |
| 86 | MP0005174_abnormal_tail_pigmentation | 1.36644119 |
| 87 | MP0000716_abnormal_immune_system | 1.36406808 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 1.33253917 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.32322912 |
| 90 | MP0009764_decreased_sensitivity_to | 1.30345400 |
| 91 | MP0005187_abnormal_penis_morphology | 1.28402902 |
| 92 | MP0001293_anophthalmia | 1.26812308 |
| 93 | MP0009697_abnormal_copulation | 1.26068652 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.25077567 |
| 95 | MP0003787_abnormal_imprinting | 1.20341177 |
| 96 | MP0010307_abnormal_tumor_latency | 1.19113371 |
| 97 | MP0005390_skeleton_phenotype | 1.17535773 |
| 98 | MP0001346_abnormal_lacrimal_gland | 1.17338238 |
| 99 | MP0002132_abnormal_respiratory_system | 1.16401817 |
| 100 | MP0002163_abnormal_gland_morphology | 1.15934419 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.15788622 |
| 102 | MP0003279_aneurysm | 1.15228934 |
| 103 | MP0000490_abnormal_crypts_of | 1.14918222 |
| 104 | MP0000733_abnormal_muscle_development | 1.13230474 |
| 105 | MP0002095_abnormal_skin_pigmentation | 1.12041130 |
| 106 | MP0003763_abnormal_thymus_physiology | 1.11711947 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 1.10217678 |
| 108 | MP0006292_abnormal_olfactory_placode | 1.08124473 |
| 109 | MP0005367_renal/urinary_system_phenotyp | 1.07982251 |
| 110 | MP0000516_abnormal_urinary_system | 1.07982251 |
| 111 | MP0002429_abnormal_blood_cell | 1.07455629 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06009027 |
| 113 | MP0000689_abnormal_spleen_morphology | 1.04646375 |
| 114 | MP0005058_abnormal_lysosome_morphology | 1.03456110 |
| 115 | MP0001873_stomach_inflammation | 1.02426647 |
| 116 | MP0002928_abnormal_bile_duct | 1.01803745 |
| 117 | MP0008995_early_reproductive_senescence | 1.01789453 |
| 118 | MP0002722_abnormal_immune_system | 1.01708853 |
| 119 | MP0000358_abnormal_cell_content/ | 1.01566572 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 1.00619956 |
| 121 | MP0001764_abnormal_homeostasis | 1.00585528 |
| 122 | MP0001905_abnormal_dopamine_level | 0.99169220 |
| 123 | MP0001986_abnormal_taste_sensitivity | 0.99022313 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.95759203 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.95597758 |
| 126 | MP0000371_diluted_coat_color | 0.93536102 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.92601638 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.91239164 |
| 129 | MP0009333_abnormal_splenocyte_physiolog | 0.90361022 |
| 130 | MP0001881_abnormal_mammary_gland | 0.88415440 |
| 131 | MP0005253_abnormal_eye_physiology | 0.87455405 |
| 132 | MP0002168_other_aberrant_phenotype | 0.87010647 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.86915721 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.86915721 |
| 135 | MP0001853_heart_inflammation | 0.85605483 |
| 136 | MP0003121_genomic_imprinting | 0.83471860 |
| 137 | MP0003795_abnormal_bone_structure | 0.83357148 |
| 138 | MP0001188_hyperpigmentation | 0.82036249 |
| 139 | MP0008004_abnormal_stomach_pH | 0.81440919 |
| 140 | MP0000703_abnormal_thymus_morphology | 0.81272140 |
| 141 | MP0005266_abnormal_metabolism | 0.81021070 |
| 142 | MP0000647_abnormal_sebaceous_gland | 0.79302590 |
| 143 | MP0000343_altered_response_to | 0.78916625 |
| 144 | MP0003828_pulmonary_edema | 0.78868308 |
| 145 | MP0005171_absent_coat_pigmentation | 0.77317880 |
| 146 | MP0002751_abnormal_autonomic_nervous | 0.76325203 |
| 147 | MP0001958_emphysema | 0.75861856 |
| 148 | MP0002277_abnormal_respiratory_mucosa | 0.75810924 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.74812721 |
| 150 | MP0008872_abnormal_physiological_respon | 0.74464994 |
| 151 | MP0002233_abnormal_nose_morphology | 0.74135673 |
| 152 | MP0009278_abnormal_bone_marrow | 0.72975655 |
| 153 | MP0002113_abnormal_skeleton_development | 0.72809459 |
| 154 | MP0005220_abnormal_exocrine_pancreas | 0.71517304 |
| 155 | MP0004142_abnormal_muscle_tone | 0.71444802 |
| 156 | MP0008007_abnormal_cellular_replicative | 0.71116424 |
| 157 | MP0001730_embryonic_growth_arrest | 0.70277458 |
| 158 | MP0000427_abnormal_hair_cycle | 0.70106033 |
| 159 | MP0002272_abnormal_nervous_system | 0.69986918 |
| 160 | MP0003941_abnormal_skin_development | 0.69359054 |
| 161 | MP0004215_abnormal_myocardial_fiber | 0.69192562 |
| 162 | MP0000465_gastrointestinal_hemorrhage | 0.67909016 |
| 163 | MP0003705_abnormal_hypodermis_morpholog | 0.67850754 |
| 164 | MP0001542_abnormal_bone_strength | 0.67488620 |
| 165 | MP0008775_abnormal_heart_ventricle | 0.67399993 |
| 166 | MP0005275_abnormal_skin_tensile | 0.66340417 |
| 167 | MP0010386_abnormal_urinary_bladder | 0.66047466 |
| 168 | MP0005023_abnormal_wound_healing | 0.65236762 |
| 169 | MP0001756_abnormal_urination | 0.64853507 |
| 170 | MP0002160_abnormal_reproductive_system | 0.59301644 |
| 171 | MP0002019_abnormal_tumor_incidence | 0.59099684 |
| 172 | MP0002837_dystrophic_cardiac_calcinosis | 0.58515212 |
| 173 | MP0002102_abnormal_ear_morphology | 0.58170332 |
| 174 | MP0005386_behavior/neurological_phenoty | 0.57772614 |
| 175 | MP0004924_abnormal_behavior | 0.57772614 |
| 176 | MP0003646_muscle_fatigue | 0.57262550 |
| 177 | MP0000313_abnormal_cell_death | 0.56293930 |
| 178 | MP0005395_other_phenotype | 0.56206291 |
| 179 | MP0001697_abnormal_embryo_size | 0.55733463 |
| 180 | MP0003937_abnormal_limbs/digits/tail_de | 0.55138915 |
| 181 | MP0005379_endocrine/exocrine_gland_phen | 0.53808820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.20209030 |
| 2 | Acute encephalopathy (HP:0006846) | 5.03732066 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.56355268 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.41497041 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.09437165 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.02054785 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.83857915 |
| 8 | Increased CSF lactate (HP:0002490) | 3.66369614 |
| 9 | Colon cancer (HP:0003003) | 3.63026668 |
| 10 | Hepatic necrosis (HP:0002605) | 3.59570886 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.46215993 |
| 12 | Cerebral edema (HP:0002181) | 3.32314753 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.24797205 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.23827956 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20345453 |
| 16 | Aplastic anemia (HP:0001915) | 3.15684094 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 3.12802020 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.07732085 |
| 19 | Optic neuritis (HP:0100653) | 3.07732085 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.07239332 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.07239332 |
| 22 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.07239332 |
| 23 | Abnormal protein glycosylation (HP:0012346) | 3.07239332 |
| 24 | Prostate neoplasm (HP:0100787) | 2.97405223 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 2.91680685 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88788429 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88788429 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.83872307 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 2.83397685 |
| 30 | Myositis (HP:0100614) | 2.80577201 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.79394294 |
| 32 | Spinal cord lesions (HP:0100561) | 2.78525977 |
| 33 | Syringomyelia (HP:0003396) | 2.78525977 |
| 34 | Orchitis (HP:0100796) | 2.78014630 |
| 35 | Respiratory failure (HP:0002878) | 2.76453187 |
| 36 | Recurrent viral infections (HP:0004429) | 2.76075368 |
| 37 | Lactic acidosis (HP:0003128) | 2.74680759 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73958408 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.73636703 |
| 40 | Periodontitis (HP:0000704) | 2.72852225 |
| 41 | Chromsome breakage (HP:0040012) | 2.71207848 |
| 42 | Gingivitis (HP:0000230) | 2.66598664 |
| 43 | Hyperglycinemia (HP:0002154) | 2.65896514 |
| 44 | Abnormality of the labia minora (HP:0012880) | 2.58910431 |
| 45 | Leukodystrophy (HP:0002415) | 2.58748828 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.57661687 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.57661687 |
| 48 | Abnormality of the nasal septum (HP:0000419) | 2.56533449 |
| 49 | IgM deficiency (HP:0002850) | 2.53418809 |
| 50 | Lipid accumulation in hepatocytes (HP:0006561) | 2.52734997 |
| 51 | Microvesicular hepatic steatosis (HP:0001414) | 2.52575308 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.52462018 |
| 53 | Respiratory difficulties (HP:0002880) | 2.51765468 |
| 54 | Optic disc pallor (HP:0000543) | 2.49403413 |
| 55 | Rectal fistula (HP:0100590) | 2.47982080 |
| 56 | Rectovaginal fistula (HP:0000143) | 2.47982080 |
| 57 | Urethral obstruction (HP:0000796) | 2.42062696 |
| 58 | Exercise intolerance (HP:0003546) | 2.41873081 |
| 59 | Osteomyelitis (HP:0002754) | 2.39762947 |
| 60 | Obstructive lung disease (HP:0006536) | 2.39220727 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39220727 |
| 62 | Oral leukoplakia (HP:0002745) | 2.38924241 |
| 63 | Exertional dyspnea (HP:0002875) | 2.38245420 |
| 64 | Abnormality of alanine metabolism (HP:0010916) | 2.37135656 |
| 65 | Hyperalaninemia (HP:0003348) | 2.37135656 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37135656 |
| 67 | Acute myeloid leukemia (HP:0004808) | 2.36945522 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.36809828 |
| 69 | Sparse eyelashes (HP:0000653) | 2.36052002 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.32632238 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.31531534 |
| 72 | Vasculitis (HP:0002633) | 2.30796519 |
| 73 | Increased serum lactate (HP:0002151) | 2.29614662 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.29565510 |
| 75 | Type 2 muscle fiber atrophy (HP:0003554) | 2.28333216 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.27467563 |
| 77 | Cellulitis (HP:0100658) | 2.26366014 |
| 78 | Pancytopenia (HP:0001876) | 2.25913660 |
| 79 | Arterial thrombosis (HP:0004420) | 2.25622807 |
| 80 | Degeneration of anterior horn cells (HP:0002398) | 2.25108854 |
| 81 | Abnormality of the anterior horn cell (HP:0006802) | 2.25108854 |
| 82 | Chronic diarrhea (HP:0002028) | 2.22136541 |
| 83 | Abnormality of the fingertips (HP:0001211) | 2.18623382 |
| 84 | Albinism (HP:0001022) | 2.17796446 |
| 85 | IgA deficiency (HP:0002720) | 2.17276175 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15058219 |
| 87 | Hip dysplasia (HP:0001385) | 2.13507436 |
| 88 | Meningitis (HP:0001287) | 2.13287565 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.12509311 |
| 90 | Recurrent skin infections (HP:0001581) | 2.11241875 |
| 91 | Adactyly (HP:0009776) | 2.10955730 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.08984202 |
| 93 | Medial flaring of the eyebrow (HP:0010747) | 2.08037166 |
| 94 | Lethargy (HP:0001254) | 2.07891765 |
| 95 | Aortic aneurysm (HP:0004942) | 2.07886817 |
| 96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07331711 |
| 97 | X-linked dominant inheritance (HP:0001423) | 2.07115456 |
| 98 | Cellular immunodeficiency (HP:0005374) | 2.05293871 |
| 99 | Poor head control (HP:0002421) | 2.02910430 |
| 100 | Abnormality of T cell number (HP:0011839) | 2.01823032 |
| 101 | Absent frontal sinuses (HP:0002688) | 2.01310638 |
| 102 | Cervical subluxation (HP:0003308) | 2.01047797 |
| 103 | Hypothermia (HP:0002045) | 2.00807757 |
| 104 | Lymphopenia (HP:0001888) | 2.00447170 |
| 105 | Eosinophilia (HP:0001880) | 2.00110293 |
| 106 | Basal ganglia calcification (HP:0002135) | 1.99617501 |
| 107 | Abnormality of the prostate (HP:0008775) | 1.99448269 |
| 108 | Thyroiditis (HP:0100646) | 1.99397045 |
| 109 | Vaginal fistula (HP:0004320) | 1.98923262 |
| 110 | Axonal loss (HP:0003447) | 1.98389494 |
| 111 | Abnormal hair whorl (HP:0010721) | 1.96900751 |
| 112 | CNS demyelination (HP:0007305) | 1.95863833 |
| 113 | Rhabdomyosarcoma (HP:0002859) | 1.95068562 |
| 114 | Postnatal microcephaly (HP:0005484) | 1.94203494 |
| 115 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94136348 |
| 116 | Congenital primary aphakia (HP:0007707) | 1.93247497 |
| 117 | Abnormality of the right ventricle (HP:0001707) | 1.92489971 |
| 118 | Pulmonary infiltrates (HP:0002113) | 1.92240158 |
| 119 | Muscle fiber atrophy (HP:0100295) | 1.91397585 |
| 120 | Increased number of teeth (HP:0011069) | 1.91272622 |
| 121 | Cheilitis (HP:0100825) | 1.91166175 |
| 122 | Stomatitis (HP:0010280) | 1.90823741 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90583312 |
| 124 | T lymphocytopenia (HP:0005403) | 1.90501154 |
| 125 | Deep philtrum (HP:0002002) | 1.89513046 |
| 126 | Aortic dissection (HP:0002647) | 1.89132060 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88356701 |
| 128 | Horseshoe kidney (HP:0000085) | 1.87023904 |
| 129 | Mesomelia (HP:0003027) | 1.86546174 |
| 130 | Abnormality of chromosome stability (HP:0003220) | 1.85574361 |
| 131 | IgG deficiency (HP:0004315) | 1.85485841 |
| 132 | Increased density of long bones (HP:0006392) | 1.83329174 |
| 133 | Abnormality of incisor morphology (HP:0011063) | 1.81728695 |
| 134 | Spondylolisthesis (HP:0003302) | 1.81297581 |
| 135 | Palpitations (HP:0001962) | 1.80895574 |
| 136 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80874958 |
| 137 | Increased cerebral lipofuscin (HP:0011813) | 1.80593115 |
| 138 | Gait imbalance (HP:0002141) | 1.79396889 |
| 139 | Glycosuria (HP:0003076) | 1.78407595 |
| 140 | Abnormality of urine glucose concentration (HP:0011016) | 1.78407595 |
| 141 | Limb hypertonia (HP:0002509) | 1.78403223 |
| 142 | Methylmalonic acidemia (HP:0002912) | 1.78135449 |
| 143 | Long eyelashes (HP:0000527) | 1.77642926 |
| 144 | Decreased muscle mass (HP:0003199) | 1.76178406 |
| 145 | Submucous cleft hard palate (HP:0000176) | 1.76162826 |
| 146 | Abnormality of macrophages (HP:0004311) | 1.75867446 |
| 147 | Nausea (HP:0002018) | 1.75828481 |
| 148 | Hematochezia (HP:0002573) | 1.75826225 |
| 149 | Inflammation of the large intestine (HP:0002037) | 1.74260122 |
| 150 | Dilatation of the ascending aorta (HP:0005111) | 1.73286652 |
| 151 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73016902 |
| 152 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72996040 |
| 153 | Shoulder girdle muscle weakness (HP:0003547) | 1.72525760 |
| 154 | Pendular nystagmus (HP:0012043) | 1.72359062 |
| 155 | Constricted visual fields (HP:0001133) | 1.71923320 |
| 156 | Intestinal fistula (HP:0100819) | 1.71821600 |
| 157 | Osteolytic defects of the hand bones (HP:0009699) | 1.71730965 |
| 158 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71730965 |
| 159 | Bifid tongue (HP:0010297) | 1.71274894 |
| 160 | Narrow palate (HP:0000189) | 1.70683462 |
| 161 | Glomerulopathy (HP:0100820) | 1.70499750 |
| 162 | Ectopic kidney (HP:0000086) | 1.70084668 |
| 163 | Fair hair (HP:0002286) | 1.69578295 |
| 164 | Cortical dysplasia (HP:0002539) | 1.68669033 |
| 165 | Increased serum pyruvate (HP:0003542) | 1.68338221 |
| 166 | Renal cortical cysts (HP:0000803) | 1.68309698 |
| 167 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.67733255 |
| 168 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.67733255 |
| 169 | Generalized hypopigmentation of hair (HP:0011358) | 1.67028085 |
| 170 | Hemoptysis (HP:0002105) | 1.66934099 |
| 171 | Hyperglycinuria (HP:0003108) | 1.66737062 |
| 172 | Aortic regurgitation (HP:0001659) | 1.65305848 |
| 173 | B lymphocytopenia (HP:0010976) | 1.65221718 |
| 174 | Abnormality of B cell number (HP:0010975) | 1.65221718 |
| 175 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.65136784 |
| 176 | Agnosia (HP:0010524) | 1.64764379 |
| 177 | Subacute progressive viral hepatitis (HP:0006572) | 1.64566523 |
| 178 | Abnormal biliary tract physiology (HP:0012439) | 1.64476388 |
| 179 | Bile duct proliferation (HP:0001408) | 1.64476388 |
| 180 | Poor suck (HP:0002033) | 1.63819267 |
| 181 | Alveolar cell carcinoma (HP:0006519) | 1.60808254 |
| 182 | Volvulus (HP:0002580) | 1.59225838 |
| 183 | Leukocytosis (HP:0001974) | 1.58751424 |
| 184 | Abnormal platelet volume (HP:0011876) | 1.58656930 |
| 185 | Distal lower limb amyotrophy (HP:0008944) | 1.58613001 |
| 186 | Gastrointestinal stroma tumor (HP:0100723) | 1.57476053 |
| 187 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.57363673 |
| 188 | Abnormality of the pericardium (HP:0001697) | 1.57108675 |
| 189 | Hypoplasia of the fovea (HP:0007750) | 1.55369600 |
| 190 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.55369600 |
| 191 | Asymmetry of the thorax (HP:0001555) | 1.54946857 |
| 192 | Lower limb amyotrophy (HP:0007210) | 1.54305430 |
| 193 | Uterine leiomyosarcoma (HP:0002891) | 1.52740581 |
| 194 | Leiomyosarcoma (HP:0100243) | 1.52740581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.11162474 |
| 2 | VRK2 | 3.56936009 |
| 3 | MAP3K14 | 3.56711350 |
| 4 | SIK3 | 3.32042663 |
| 5 | FRK | 3.10377451 |
| 6 | TXK | 3.01682032 |
| 7 | ZAK | 3.01143826 |
| 8 | EIF2AK3 | 2.83168313 |
| 9 | JAK3 | 2.82572509 |
| 10 | SRPK1 | 2.57158668 |
| 11 | STK16 | 2.36970314 |
| 12 | MST4 | 2.36738697 |
| 13 | EIF2AK1 | 2.26771021 |
| 14 | TNIK | 2.16539850 |
| 15 | WNK3 | 2.12857877 |
| 16 | IRAK4 | 2.08774552 |
| 17 | PBK | 2.04395347 |
| 18 | MAP4K1 | 2.02949811 |
| 19 | PDK2 | 1.97885059 |
| 20 | FGFR3 | 1.96954821 |
| 21 | TRIM28 | 1.93621411 |
| 22 | VRK1 | 1.92707592 |
| 23 | RPS6KA4 | 1.87856788 |
| 24 | JAK1 | 1.87200113 |
| 25 | MAP2K7 | 1.86244121 |
| 26 | TSSK6 | 1.81721922 |
| 27 | MKNK2 | 1.81298880 |
| 28 | MAP3K12 | 1.80077453 |
| 29 | CDK12 | 1.79340906 |
| 30 | NEK1 | 1.78176144 |
| 31 | IRAK3 | 1.77178281 |
| 32 | KIT | 1.76092968 |
| 33 | NME1 | 1.75491457 |
| 34 | ERBB3 | 1.69533727 |
| 35 | CHUK | 1.65517498 |
| 36 | NEK9 | 1.64933547 |
| 37 | MKNK1 | 1.63855830 |
| 38 | TYK2 | 1.62701266 |
| 39 | PIM2 | 1.61320795 |
| 40 | CSF1R | 1.58676094 |
| 41 | TAF1 | 1.57723562 |
| 42 | DMPK | 1.55958367 |
| 43 | TBK1 | 1.53606419 |
| 44 | TAOK3 | 1.53439750 |
| 45 | LATS1 | 1.50260511 |
| 46 | DYRK3 | 1.49289348 |
| 47 | EPHA3 | 1.43972547 |
| 48 | TGFBR2 | 1.40762555 |
| 49 | IKBKB | 1.40508476 |
| 50 | PIK3CG | 1.39177821 |
| 51 | CDC7 | 1.39119211 |
| 52 | BLK | 1.38656783 |
| 53 | DAPK1 | 1.38193308 |
| 54 | CSNK1G3 | 1.36562879 |
| 55 | MAP3K4 | 1.34017745 |
| 56 | NUAK1 | 1.33194261 |
| 57 | CSNK1G1 | 1.32557138 |
| 58 | TEC | 1.31150346 |
| 59 | NME2 | 1.29287502 |
| 60 | MAP3K13 | 1.28242403 |
| 61 | CSNK1G2 | 1.28075272 |
| 62 | MAP4K2 | 1.27693470 |
| 63 | DYRK2 | 1.27658068 |
| 64 | STK10 | 1.27497501 |
| 65 | TRPM7 | 1.26644324 |
| 66 | STK3 | 1.26304107 |
| 67 | SGK2 | 1.25484653 |
| 68 | PASK | 1.24044992 |
| 69 | IKBKE | 1.21923835 |
| 70 | PINK1 | 1.20137782 |
| 71 | BRD4 | 1.19630608 |
| 72 | RIPK4 | 1.19621099 |
| 73 | PLK1 | 1.17705534 |
| 74 | BCR | 1.15685141 |
| 75 | SIK1 | 1.14697263 |
| 76 | PIK3CA | 1.13896725 |
| 77 | INSRR | 1.13803054 |
| 78 | EIF2AK2 | 1.12315129 |
| 79 | NLK | 1.12311254 |
| 80 | PAK4 | 1.11574326 |
| 81 | TTN | 1.11501007 |
| 82 | BCKDK | 1.11204678 |
| 83 | HCK | 1.10637442 |
| 84 | SGK3 | 1.08683957 |
| 85 | PRKCH | 1.08610151 |
| 86 | CSNK1A1L | 1.08047554 |
| 87 | TTK | 1.08015396 |
| 88 | CASK | 1.04379159 |
| 89 | BMPR1B | 1.02324122 |
| 90 | PLK4 | 1.01363643 |
| 91 | AKT3 | 0.98972298 |
| 92 | SYK | 0.98342138 |
| 93 | CDK8 | 0.96110056 |
| 94 | MUSK | 0.95621077 |
| 95 | BTK | 0.88969548 |
| 96 | ERN1 | 0.86828985 |
| 97 | ITK | 0.86766312 |
| 98 | YES1 | 0.86518261 |
| 99 | LYN | 0.84342516 |
| 100 | PRKCQ | 0.83111677 |
| 101 | LCK | 0.80341289 |
| 102 | ATR | 0.78228223 |
| 103 | CAMK1D | 0.77889979 |
| 104 | TIE1 | 0.76611269 |
| 105 | ERBB4 | 0.76123268 |
| 106 | PLK2 | 0.74804400 |
| 107 | CCNB1 | 0.74479148 |
| 108 | BRSK2 | 0.73257710 |
| 109 | ALK | 0.72826426 |
| 110 | OBSCN | 0.68448252 |
| 111 | ZAP70 | 0.66584657 |
| 112 | TAOK2 | 0.66202805 |
| 113 | CDK6 | 0.64920631 |
| 114 | PIM1 | 0.64849124 |
| 115 | STK24 | 0.61141391 |
| 116 | KDR | 0.61032208 |
| 117 | CSNK2A2 | 0.59763720 |
| 118 | SIK2 | 0.59337511 |
| 119 | EPHB2 | 0.58966222 |
| 120 | RIPK1 | 0.58027559 |
| 121 | PRKCG | 0.57618513 |
| 122 | SCYL2 | 0.56634400 |
| 123 | AURKB | 0.55730845 |
| 124 | LIMK1 | 0.54777901 |
| 125 | TESK2 | 0.54382903 |
| 126 | MAP3K5 | 0.53912762 |
| 127 | MYLK | 0.53267783 |
| 128 | IGF1R | 0.52189918 |
| 129 | MAPKAPK2 | 0.51518544 |
| 130 | CSK | 0.51099361 |
| 131 | CSNK2A1 | 0.49587254 |
| 132 | PRKCD | 0.48331784 |
| 133 | EGFR | 0.45841217 |
| 134 | PDGFRB | 0.45758198 |
| 135 | PRKCE | 0.45445738 |
| 136 | CAMK1G | 0.44749322 |
| 137 | ABL1 | 0.44407053 |
| 138 | RPS6KB1 | 0.44122926 |
| 139 | MARK3 | 0.43378934 |
| 140 | TESK1 | 0.42284043 |
| 141 | PLK3 | 0.42257407 |
| 142 | AURKA | 0.42166864 |
| 143 | GRK7 | 0.41464663 |
| 144 | MAP3K10 | 0.41100670 |
| 145 | ATM | 0.39176592 |
| 146 | CHEK2 | 0.39082207 |
| 147 | STK4 | 0.38490134 |
| 148 | JAK2 | 0.37583810 |
| 149 | CSNK1E | 0.36948478 |
| 150 | FGFR1 | 0.35080207 |
| 151 | AKT1 | 0.34293291 |
| 152 | PTK6 | 0.34274602 |
| 153 | INSR | 0.34240574 |
| 154 | CDK9 | 0.33841846 |
| 155 | SGK1 | 0.33658927 |
| 156 | WEE1 | 0.33526418 |
| 157 | TGFBR1 | 0.32868913 |
| 158 | LRRK2 | 0.32265439 |
| 159 | GRK1 | 0.31834022 |
| 160 | FYN | 0.31744383 |
| 161 | CDK3 | 0.31068409 |
| 162 | RPS6KA5 | 0.29727162 |
| 163 | ADRBK2 | 0.29095658 |
| 164 | DYRK1A | 0.28852282 |
| 165 | PRKG2 | 0.27531491 |
| 166 | CAMK2D | 0.27436616 |
| 167 | FGR | 0.26823172 |
| 168 | ACVR1B | 0.26233261 |
| 169 | CSNK1A1 | 0.25021025 |
| 170 | CAMK2A | 0.24450987 |
| 171 | ADRBK1 | 0.22552232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.94359675 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.32007711 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.30374123 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.90236368 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.78782394 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.70360894 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.56627987 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41870897 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31166251 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01684116 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97180258 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 1.95694549 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91900697 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89480703 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85535427 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.84192397 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.83460100 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.81744721 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.81445910 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.80609711 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79303333 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78293166 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76016219 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75858559 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.73623195 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.72672074 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72411030 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.71889951 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71403689 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.70881959 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.66850887 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.62090278 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61845096 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.61279148 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59641785 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.57529523 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56480357 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55621908 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54473237 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52625297 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.51441665 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.48232230 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47578159 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46420262 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45881538 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38631670 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37583428 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35232428 |
| 49 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.35145509 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.33433285 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.33023365 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32001785 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28739269 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.28247456 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28138359 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.28071549 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26988102 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24096217 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23569295 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23380145 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 1.22919444 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21157996 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 1.19276717 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.18968943 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18596792 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17729728 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16898084 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16346741 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13889274 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13138603 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12568271 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10617406 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10245219 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09927877 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09443248 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08001173 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07715750 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 1.07232603 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 1.05346963 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03354388 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03241374 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99640318 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98350762 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96871453 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96729672 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96044884 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95695757 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95639187 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95015296 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94846738 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94816729 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92726380 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91713969 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.91106653 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.90918682 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.90346893 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89748384 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89327467 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88116696 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87233783 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86570857 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84797935 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84653214 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83979069 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83517927 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83117569 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.83106184 |
| 108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81123780 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.79882817 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79163868 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.78369940 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78112753 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78085340 |
| 114 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77645857 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.76667226 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75464521 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74817304 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74373609 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73361245 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72925428 |
| 121 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72628602 |
| 122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72471419 |
| 123 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71611503 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.70778463 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69795776 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68469465 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68418215 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68084716 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67789558 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.67046307 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65649510 |
| 132 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65311557 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65251114 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65168810 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63606762 |
| 136 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.58917240 |
| 137 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58806517 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58512346 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56687342 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55910721 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55098815 |
| 142 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53933099 |
| 143 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53928846 |
| 144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53183866 |
| 145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52684952 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52666109 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51414923 |
| 148 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51057672 |
| 149 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50983254 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50374393 |
| 151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50035106 |
| 152 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49293921 |
| 153 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49202704 |
| 154 | Cell cycle_Homo sapiens_hsa04110 | 0.48951831 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48669240 |
| 156 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48627559 |
| 157 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47986889 |
| 158 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47668400 |
| 159 | Glioma_Homo sapiens_hsa05214 | 0.47157885 |
| 160 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47025232 |
| 161 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46644100 |
| 162 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46566921 |
| 163 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46473249 |
| 164 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44293948 |
| 165 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44041430 |
| 166 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40605354 |
| 167 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40075757 |
| 168 | Phototransduction_Homo sapiens_hsa04744 | 0.40033397 |
| 169 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33104140 |
| 170 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29995541 |
| 171 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.24444882 |
| 172 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23027753 |
| 173 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21847917 |
| 174 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21499996 |
| 175 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18734248 |
| 176 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.17130853 |

